These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18622373)

  • 21. Evaluation of the Performance of a Fecal Tumor M2-PK Rapid Kit Using Stool Specimens for Detection of Colorectal Tumors.
    Cho CH; Kim J; Jang MA; Lee BJ; Park JJ; Lim CS
    Ann Clin Lab Sci; 2016; 46(2):154-60. PubMed ID: 27098621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study.
    Shastri YM; Loitsch S; Hoepffner N; Povse N; Hanisch E; Rösch W; Mössner J; Stein JM
    Am J Gastroenterol; 2008 Jun; 103(6):1496-504. PubMed ID: 18510609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecal biomarkers do not always identify pre-cancerous lesions in patients who present in primary care with bowel symptoms.
    Keenan J; Aitchison A; Leaman J; Pearson J; Frizelle F
    N Z Med J; 2019 Aug; 132(1501):48-56. PubMed ID: 31465327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.
    Tonus C; Sellinger M; Koss K; Neupert G
    World J Gastroenterol; 2012 Aug; 18(30):4004-11. PubMed ID: 22912551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
    Gearry R; Barclay M; Florkowski C; George P; Walmsley T
    N Z Med J; 2005 May; 118(1214):U1444. PubMed ID: 15886739
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK.
    Schneider J; Bitterlich N; Schulze G
    Anticancer Res; 2005; 25(3A):1507-15. PubMed ID: 16033052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention.
    Koss K; Maxton D; Jankowski JA
    Colorectal Dis; 2008 Mar; 10(3):244-8. PubMed ID: 17784868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy.
    Hardt PD; Ewald N
    Expert Rev Mol Diagn; 2008 Sep; 8(5):579-85. PubMed ID: 18785806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study.
    Haug U; Hundt S; Brenner H
    Br J Cancer; 2008 Jul; 99(1):133-5. PubMed ID: 18542075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal canhcer.
    Demır AS; Erdenen F; Müderrısoğlu C; Toros AB; Bektaş H; Gelışgen R; Tabak Ö; Altunoğlu E; Uzun H; Erdem Huq GE; Aral H
    Turk J Gastroenterol; 2013; 24(1):36-42. PubMed ID: 23794342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer.
    Sithambaram S; Hilmi I; Goh KL
    PLoS One; 2015; 10(7):e0131616. PubMed ID: 26158845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.
    Hardt PD; Mazurek S; Toepler M; Schlierbach P; Bretzel RG; Eigenbrodt E; Kloer HU
    Br J Cancer; 2004 Aug; 91(5):980-4. PubMed ID: 15266315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer.
    Uppara M; Adaba F; Askari A; Clark S; Hanna G; Athanasiou T; Faiz O
    World J Surg Oncol; 2015 Feb; 13():48. PubMed ID: 25888768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
    Schneider J; Schulze G
    Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis.
    Nasir Kansestani A; Zare ME; Tong Q; Zhang J
    Sci Rep; 2022 Feb; 12(1):2623. PubMed ID: 35173276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
    Haug U; Rothenbacher D; Wente MN; Seiler CM; Stegmaier C; Brenner H
    Br J Cancer; 2007 May; 96(9):1329-34. PubMed ID: 17406361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.
    Oremek GM; Teigelkamp S; Kramer W; Eigenbrodt E; Usadel KH
    Anticancer Res; 1999; 19(4A):2599-601. PubMed ID: 10470201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.